SEC Form 4 · accession 0001140361-15-000967
PROVECTUS BIOPHARMACEUTICALS, INC. · PVCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy Scott Ph.D.
Officer — President · Director
Period of report
Jan 7, 2015
Accepted (ET)
Jan 7, 2015 · 3:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000315545
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 7, 2015 | M | 76,764 | $0.64 | A | 503,125 | I | 401(k) Plan |
| Common Stock | holding | — | — | — | 1,521,845 | D | ||
| Common Stock | holding | — | — | — | 55,996 | I | Family Limited Partnership |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.64 | Jan 7, 2015 | M | 76,764 | D | — | Jan 7, 2015 | Common Stock | 76,764 | 0 | D |
Explanation of responses
- F1The option, representing the right to purchase a total of 300,000 shares, became exercisable in four equal annual installments beginning on January 7, 2006.